Polycaprolactone material containing stilbene structure as well as preparation method and application of polycaprolactone material
By introducing styrene structure into polycaprolactone materials, it has fluorescence effect under ultraviolet light, the problem of difficult to monitor material degradation in the prior art is solved, and material degradation observation in the fields of biomedical and medical beauty has been achieved and control.
Patent Information
- Application Number
- CN202411040232.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-31
- Publication Date
- 2024-11-19
AI Technical Summary
In the application of existing polycaprolactone materials in the fields of biomedical and medical beauty, it is difficult to intuitively monitor their degradation in the human body, and there is a lack of effective degradation observation methods.
A polycaprolactone material containing styrene structure has been developed, which has fluorescence effect at specific wavelengths through ultraviolet irradiation. It is used to prepare surgical sutures, tissue engineering stents and drug sustained-release capsules to realize the material in the human body. Intuitive observation of the degree of degradation. The material is prepared under the protection of inert gas, using compounds A and ε-caprolactone as raw materials, and using specific catalyst and solvent systems to ensure the stability and high purity of the product.
It realizes the direct observation of the degradation of polycaprolactone materials through ultraviolet irradiation in the human body, improves the biocompatibility and degradation controllability of the materials, and is suitable for applications in the fields of biomedical and medical beauty.
Smart Images

Figure CN118978673A_ABST
Abstract
Description
Technical Field
[0001] The present application relates to the technical field of polycaprolactone, and in particular to a polycaprolactone material containing a stilbene structure, a preparation method thereof, and an application thereof. Background Art
[0002] Polycaprolactone (PCL) has been widely used in the biomedical field due to its excellent biocompatibility and non-toxicity, such as surgical sutures, tissue engineering scaffolds, and drug-release capsules. It also has excellent biodegradability and can be completely degraded within 6 to 12 months in natural environments.
[0003] In recent years, polycaprolactone has emerged as a new force in the medical beauty field due to its excellent performance, has achieved rapid development, and has become a new darling of the medical beauty market at home and abroad. Summary of the Invention
[0004] The present application provides a polycaprolactone material containing a distyrene structure, a preparation method thereof, and an application thereof, wherein the degree of degradation of the polycaprolactone material during use can be observed by ultraviolet irradiation.
[0005] The embodiment of the present application is implemented as follows:
[0006] In the first aspect, the present application provides an example of a polycaprolactone material containing a stilbene structure, the structural formula of which is as follows:
[0007]
[0008] The ranges of m and n are 20 to 50 respectively.
[0009] In the above technical scheme, the polycaprolactone material containing a diphenylethylene structure of the present application includes a diphenylethylene structure, which enables it to have a fluorescent effect under ultraviolet light of a specific wavelength. The polycaprolactone material containing a diphenylethylene structure can be used to prepare surgical sutures, tissue engineering scaffolds and drug sustained-release capsules. After being implanted into the human dermis, the degree of degradation of the material in the human body can be observed very intuitively by ultraviolet irradiation.
[0010] In the second aspect, the present application provides an example of a method for preparing a polycaprolactone material containing a distyrene structure in the above embodiment, which comprises: reacting a third raw material at a temperature of 105°C to 120°C for 20h to 36h under inert gas protection, detecting by GPC that the weight average molecular weight of the product reaches 20,000 to 50,000, and stopping the reaction. The third raw material comprises 0.02 equivalents to 0.05 equivalents of compound A, 1 equivalent of ε-caprolactone, 0.0001 equivalents to 0.001 equivalents of a catalyst, and 3 equivalents to 5 equivalents of a second solvent. The structural formula of compound A is as follows:
[0011]
[0012] In the above technical scheme, the preparation method of the present application uses compound A and ε-caprolactone as raw materials to prepare a polycaprolactone material containing a diphenylethylene structure. The preparation method is simple, and the obtained polycaprolactone material containing a diphenylethylene structure has a stable structure and can be used to prepare surgical sutures, tissue engineering scaffolds and drug sustained-release capsules. After being implanted into the human dermis, the degree of degradation of the material in the human body can be observed very intuitively by ultraviolet irradiation.
[0013] In some possible embodiments, before reacting the third raw material, the second raw material is first heated to reflux in the second solvent, and water in the second raw material is removed through a water separator, and the reflux is maintained for 3 to 5 hours. The second raw material includes 0.02 to 0.05 equivalents of compound A, 1 equivalent of ε-caprolactone, and 3 to 5 equivalents of the second solvent.
[0014] In the above example, before adding the catalyst to the system, the moisture in the second raw material is first removed through the second solvent reflux and water separator to avoid or reduce side reactions in the system and improve the yield and purity.
[0015] In some possible embodiments, after the reflux is completed, the water content in the second raw material is sampled and detected to be ≤100 ppm, and then 0.0001 equivalent to 0.001 equivalent of catalyst is added to the second raw material.
[0016] In the above example, after the reflux is completed, the water content in the second raw material is detected by sampling and is ≤100 ppm, which can ensure that the water content in the system is low.
[0017] In some possible embodiments, after the third raw material completes the reaction, a second mixture is prepared. After the second mixture is cooled to 5°C to 35°C, the second mixture is first diluted with an organic solvent, and then extracted and separated to obtain an organic phase. The organic phase is then distilled and concentrated to obtain a concentrated organic phase. Finally, the concentrated organic phase is mixed with a poor solvent to precipitate and crystallize the polycaprolactone material containing a distyrene structure.
[0018] In the above example, extraction can remove water-soluble impurities and residual catalysts in the system.
[0019] In some possible embodiments, compound A is prepared by the following method:
[0020] Under inert gas protection, a solution containing titanium tetrachloride is added dropwise to the first raw material in a stirring state. After the addition is completed, the stirring state is maintained at 20°C to 50°C for 1 hour to 12 hours. The first raw material includes 1 equivalent of vanillin, 1.2 equivalents to 3 equivalents of a reducing agent, and 20 equivalents to 30 equivalents of a first solvent, and the solution containing titanium tetrachloride includes 2 equivalents to 4 equivalents of titanium tetrachloride and 10 equivalents to 20 equivalents of the first solvent.
[0021] In the above example, the preparation method of the present application uses vanillin, titanium tetrachloride, and a reducing agent as raw materials to prepare Compound A. The preparation method is simple, and the obtained Compound A can be used to synthesize a polycaprolactone material containing a stilbene structure with ε-caprolactone. Vanillin is a widely used edible flavoring that can be extracted from vanilla seeds. Through chemical synthesis, a diol containing a stilbene structure, namely Compound A, can be obtained.
[0022] In some possible embodiments, when the solution containing titanium tetrachloride is added dropwise to the first raw material, the temperature of the first raw material is maintained at -70°C to -20°C.
[0023] In the above example, when the solution containing titanium tetrachloride is added dropwise to the first raw material, the reaction rate between titanium tetrachloride and the reducing agent can be controlled by maintaining the temperature of the first raw material at a low level.
[0024] In some possible embodiments, after the first raw material completes the reaction, a first mixture is prepared, and the pH value of the first mixture is adjusted to 1-3 with an acid, and the mixture is stirred and filtered to obtain a solid compound A.
[0025] In the above example, after the first mixture is prepared, the reducing agent in the first mixture can be removed by adjusting the pH value of the first mixture to 1-3 using an acid.
[0026] In some possible embodiments, the reducing agent includes any one or more of zinc powder, iron powder, and magnesium powder.
[0027] In a third aspect, the present application provides an example of the use of the polycaprolactone material containing a distyrene structure in the above embodiment in the preparation of surgical sutures, tissue engineering scaffolds and drug sustained-release capsules. BRIEF DESCRIPTION OF THE DRAWINGS
[0028] In order to more clearly illustrate the technical solutions of the embodiments of the present application, the following is a brief introduction to the drawings required for use in the embodiments. It should be understood that the following drawings only show certain embodiments of the present application and therefore should not be regarded as limiting the scope. For ordinary technicians in this field, other relevant drawings can be obtained based on these drawings without creative work.
[0029] Figure 1Schematic diagram of the process for preparing a polycaprolactone material containing a stilbene structure according to an embodiment of the present application;
[0030] Figure 2 This is an infrared spectrum of the polycaprolactone material containing a stilbene structure prepared in Example 1 of the present application;
[0031] Figure 3 This is the NMR comparison image of the polycaprolactone material containing stilbene structure prepared in Example 1 of the present application;
[0032] Figure 4 Schematic diagram of the absorption peaks of the polycaprolactone containing a styrene structure prepared in Example 1 of the present application and the polycaprolactone without a styrene structure prepared in Comparative Example 1 under ultraviolet light with a wavelength of 100 to 400 nm. DETAILED DESCRIPTION
[0033] The embodiments of the present application will be described in detail below with reference to the examples, but it will be understood by those skilled in the art that the following examples are merely illustrative of the present application and should not be considered as limiting the scope of the present application. In the examples, if specific conditions are not specified, the conditions are carried out according to conventional conditions or manufacturer recommendations. The reagents or instruments used are not specified by the manufacturer and are conventional products that can be purchased commercially.
[0034] The following is a detailed description of a polycaprolactone material containing a stilbene structure, a preparation method thereof, and an application thereof according to an embodiment of the present application:
[0035] The present application provides a polycaprolactone material containing a stilbene structure, the structural formula of which is as follows:
[0036]
[0037] Here, m and n are 20 to 50 respectively.
[0038] As an example, m may be 20, 25, 30, 35, 40, 45, or 50; and n may be 20, 25, 30, 35, 40, 45, or 50.
[0039] It should be noted that the values of m and n can be the same or different.
[0040] The polycaprolactone material of the present application includes a diphenylethylene structure, which enables it to have a fluorescent effect under ultraviolet light of a specific wavelength of 365nm. The polycaprolactone material containing a diphenylethylene structure can be used to prepare surgical sutures, tissue engineering scaffolds and drug sustained-release capsules. After being implanted into the human dermis, the degree of degradation of the material in the human body can be observed very intuitively by ultraviolet irradiation.
[0041] See also Figure 1The present application also provides a method for preparing the polycaprolactone material containing a stilbene structure in the above embodiment, which comprises the following steps:
[0042] S1. Preparation of Compound A
[0043] First, prepare a low-temperature tank with a magnetic stirring device. The temperature of the low-temperature tank is -70°C to -20°C. Weigh 1 equivalent of vanillin, 1.2 equivalents to 3 equivalents of a reducing agent, and 20 equivalents to 30 equivalents of a first solvent into a reaction vessel. Place the reaction vessel in the low-temperature tank and start magnetic stirring under inert gas protection.
[0044] Then, 2 equivalents to 4 equivalents of titanium tetrachloride are weighed and dissolved in 10 equivalents to 20 equivalents of the first solvent to prepare a solution containing titanium tetrachloride. The solution containing titanium tetrachloride is slowly added dropwise to the reaction vessel over 0.5 to 6 hours. After the addition is completed, the reaction vessel is transferred to a water bath at 20° C. to 50° C. and reacted for 1 to 12 hours.
[0045] After the reaction is completed, a first mixture is prepared, and the pH value of the first mixture is adjusted to 1-3 with an acid. After stirring for 0.5-2 hours, the mixture is filtered to obtain a solid compound A, which is vacuum-dried to remove the first solvent.
[0046] The structural formula of compound A is as follows:
[0047]
[0048] As an example, the temperature of the cryogenic bath may be -70°C, -65°C, -60°C, -55°C, -50°C, -45°C, -40°C, -35°C, -30°C, -25°C, or -20°C.
[0049] Optionally, the temperature of the low-temperature tank is -70°C to -30°C.
[0050] Optionally, the temperature of the low-temperature tank is -70°C to -40°C.
[0051] Optionally, the temperature of the low-temperature tank is -70°C to -50°C.
[0052] In some exemplary embodiments, the reducing agent includes any one or more of zinc powder, iron powder, and magnesium powder.
[0053] As an example, the reducing agent can be zinc powder, iron powder or magnesium powder alone, or a mixture of zinc powder and iron powder, or a mixture of iron powder and magnesium powder, or a mixture of zinc powder and magnesium powder, or a mixture of zinc powder, iron powder and magnesium powder.
[0054] In some exemplary embodiments, the first solvent includes tetrahydrofuran.
[0055] In some exemplary embodiments, the inert gas includes any one or more of nitrogen, helium, argon, and xenon.
[0056] As an example, the temperature of the water bath reaction can be 20°C, 25°C, 30°C, 35°C, 40°C, 45°C or 50°C; the time of the water bath reaction can be 1 h, 2 h, 3 h, 5 h, 10 h, 11 h or 12 h.
[0057] Optionally, the temperature of the water bath reaction is 20° C. to 30° C., and the time of the water bath reaction is 2 h to 5 h.
[0058] In some exemplary embodiments, the acid used to adjust the first mixture includes 1 mol / L hydrochloric acid.
[0059] S2. Preparation of polycaprolactone material containing stilbene structure
[0060] First, add 0.02 equivalent to 0.05 equivalent of compound A, 1 equivalent of ε-caprolactone and 3 equivalents to 5 equivalents of the second solvent into a reaction vessel equipped with a mechanical stirring device, a heating device, a gas guide tube, a water separator, a thermometer and a condenser, heat to reflux the second solvent under the protection of inert gas, and maintain reflux for 3 hours to 5 hours;
[0061] After the reflux is completed, the water content in the reaction vessel is sampled and tested to be ≤100 ppm, and then 0.0001 equivalent to 0.001 equivalent of catalyst is added to the reaction vessel, and the reaction is carried out at a temperature of 105° C. to 120° C. for 20 h to 36 h. The weight average molecular weight of the product is detected by GPC to reach 20,000 to 50,000, and the reaction is stopped;
[0062] After the reaction is completed, a second mixture is prepared. After the second mixture is cooled to 5°C to 35°C, the second mixture is first diluted with an organic solvent, and then extracted and separated to obtain an organic phase. The organic phase is then distilled and concentrated to obtain a concentrated organic phase. Finally, the concentrated organic phase is mixed with a poor solvent to precipitate and crystallize a polycaprolactone material containing a distyrene structure. Finally, the precipitated and crystallized polymer is dried at 30°C to 60°C to remove the residual solvent.
[0063] In some exemplary embodiments, the second solvent includes toluene.
[0064] As an example, the reflow time may be 3 h, 3.5 h, 4 h, 4.5 h or 5 h.
[0065] In some exemplary embodiments, the catalyst includes stannous octoate.
[0066] In some exemplary embodiments, the reaction temperature of compound A and ε-caprolactone can be 105°C, 106°C, 107°C, 108°C, 109°C, 110°C, 111°C, 112°C, 113°C, 114°C, 115°C, 116°C, 117°C, 118°C, 119°C or 120°C; the reaction time of compound A and ε-caprolactone can be 20h, 21h, 22h, 23h, 24h, 25h, 26h, 27h, 28h, 29h, 30h, 31h, 32h, 33h, 34h, 35h or 36h.
[0067] In some exemplary embodiments, the organic solvent includes dichloromethane or ethyl acetate.
[0068] In some exemplary embodiments, the poor solvent includes petroleum ether, diethyl ether, methanol, or ethanol.
[0069] The preparation method of the present application first uses vanillin, titanium tetrachloride and a reducing agent as raw materials to prepare compound A, and then uses compound A and ε-caprolactone as raw materials to prepare a polycaprolactone material containing a stilbene structure. The preparation method is simple, and the obtained polycaprolactone material containing a stilbene structure has a stable structure and can be used to prepare surgical sutures, tissue engineering scaffolds and drug sustained-release capsules. After being implanted in the human dermis, the degree of degradation of the material in the human body can be very intuitively observed by ultraviolet irradiation.
[0070] The present application also provides a use of the polycaprolactone material containing a stilbene structure in the above embodiment in the preparation of surgical sutures, tissue engineering scaffolds and drug sustained-release capsules.
[0071] The following is a further detailed description of a polycaprolactone material containing a stilbene structure and a preparation method thereof of the present application in conjunction with examples.
[0072] Example 1
[0073] The present application provides a polycaprolactone material containing a stilbene structure and a preparation method thereof, which comprises the following steps:
[0074] S1. Preparation of Compound A
[0075] First, prepare a cryogenic tank with a magnetic stirring device at -70°C. Weigh 5g of vanillin, 2.58g of zinc powder, and 30mL of tetrahydrofuran into a 100mL three-necked flask. Place the three-necked flask in the cryogenic tank and start magnetic stirring under nitrogen protection.
[0076] Then, 12.46 g of titanium tetrachloride was weighed and dissolved in 30 mL of dried tetrahydrofuran to prepare a solution containing titanium tetrachloride. The solution containing titanium tetrachloride was slowly added dropwise to the three-necked flask over 3 hours. After the addition was completed, the reaction vessel was transferred to a 25°C water bath and reacted for 3 hours.
[0077] After the reaction was completed, a first mixture was prepared. The pH value of the first mixture was adjusted to 2 with 1 mol / L hydrochloric acid. After stirring for 1 hour, the mixture was filtered to obtain a solid compound A, which was then dried in vacuo at 50° C. to remove tetrahydrofuran.
[0078] The structural formula of compound A is as follows:
[0079]
[0080] S2. Preparation of polycaprolactone material containing stilbene structure
[0081] First, add 4.76g of compound A, 100g of ε-caprolactone and 200mL of toluene into a reaction vessel equipped with a mechanical stirrer, a heater, a gas guide tube, a water separator, a thermometer and a condenser. Heat to toluene reflux under nitrogen protection and maintain reflux for 3h.
[0082] After the reflux is completed, the water content in the reaction vessel is sampled and tested to be ≤100 ppm. Then, 0.472 g of stannous octoate is added to the reaction vessel, and the reaction is carried out at a temperature of 110° C. for 30 h. GPC is used to detect that the weight average molecular weight of the product reaches 20,000 and the PDI is 1.78, and the reaction is stopped.
[0083] After the reaction is completed, a second mixture is obtained. After the second mixture is cooled to 20°C, the second mixture is diluted with 2L of ethyl acetate, and then extracted with 500mL of purified water three times and 500mL of saturated brine once. The organic phase is separated and dried over anhydrous sodium sulfate. The organic phase is then distilled and concentrated to obtain a concentrated organic phase. Finally, the concentrated organic phase is mixed with 2L of anhydrous ethanol to precipitate and crystallize the polycaprolactone material containing a diphenylethylene structure. Finally, the precipitated and crystallized polymer is dried at 50°C to remove the residual solvent.
[0084] The infrared spectrum of the polycaprolactone material containing stilbene structure obtained in Example 1 is as follows: Figure 2 shown.
[0085] The NMR solvent is deuterated DMSO, a-4.7ppm, b-3.62ppm, c-1.29ppm, d-1.66ppm, e-2.52ppm, f-3.87ppm, g-7.35ppm, h-7.42ppm, i-7.15ppm, j-6.95ppm, for comparison Figure 3 , proving that the polycaprolactone material containing distyrene structure was successfully synthesized.
[0086] Example 2
[0087] The present application provides a polycaprolactone material containing a stilbene structure and a preparation method thereof, which comprises the following steps:
[0088] S1. Preparation of Compound A
[0089] First, prepare a cryogenic tank with a magnetic stirring device at -70°C. Weigh 50g of vanillin, 25.8g of zinc powder, and 300mL of tetrahydrofuran into a 1000mL three-necked flask. Place the three-necked flask in the cryogenic tank and start magnetic stirring under nitrogen protection.
[0090] Then, 124.6 g of titanium tetrachloride was weighed and dissolved in 300 mL of dried tetrahydrofuran to prepare a solution containing titanium tetrachloride. The solution containing titanium tetrachloride was slowly added dropwise to the three-necked flask over 3 hours. After the addition was completed, the reaction vessel was transferred to a 25°C water bath and reacted for 3 hours.
[0091] After the reaction was completed, a first mixture was prepared. The pH value of the first mixture was adjusted to 2 with 1 mol / L hydrochloric acid. After stirring for 1 hour, the mixture was filtered to obtain a solid compound A, which was then dried in vacuo at 50° C. to remove tetrahydrofuran.
[0092] The structural formula of compound A is as follows:
[0093]
[0094] S2. Preparation of polycaprolactone material containing stilbene structure
[0095] First, add 47.6g of compound A, 1000g of ε-caprolactone and 2000mL of toluene into a reaction vessel equipped with a mechanical stirrer, a heater, a gas guide tube, a water separator, a thermometer and a condenser. Heat to toluene reflux under nitrogen protection and maintain reflux for 3h.
[0096] After the reflux is completed, the water content in the reaction vessel is sampled and tested to be ≤100 ppm. Then, 4.72 g of stannous octoate is added to the reaction vessel, and the reaction is carried out at a temperature of 110° C. for 30 h. GPC detection shows that the weight average molecular weight of the product reaches 21,000 and the PDI is 1.82, and the reaction is stopped.
[0097] After the reaction is completed, a second mixture is obtained. After the second mixture is cooled to 20°C, it is diluted with 20L of ethyl acetate, then extracted three times with 5000mL of purified water and once with 5000mL of saturated brine, and the organic phase is separated and dried over anhydrous sodium sulfate. The organic phase is then distilled and concentrated to obtain a concentrated organic phase. Finally, the concentrated organic phase is mixed with 20L of anhydrous ethanol to precipitate and crystallize the polycaprolactone material containing a diphenylethylene structure. Finally, the precipitated and crystallized polymer is dried at 50°C to remove the residual solvent.
[0098] Comparative Example 1
[0099] Add 2.9 g of dodecanol, 100 g of ε-caprolactone and 200 mL of toluene into a reaction vessel equipped with a mechanical stirring device, a heating device, a gas guide tube, a water separator, a thermometer and a condenser. Heat to toluene reflux under nitrogen protection and maintain reflux for 3 h.
[0100] After the reflux is completed, the water content in the reaction vessel is sampled and tested to be ≤100 ppm. Then, 0.71 g of stannous octoate is added to the reaction vessel, and the reaction is carried out at a temperature of 110° C. for 30 h. GPC is used to detect that the weight average molecular weight of the product reaches 30,000 and the PDI is 2.00, and the reaction is stopped.
[0101] After the reaction is completed, the second mixture is diluted with 2L of ethyl acetate, and then extracted with 500mL of purified water three times and 500mL of saturated brine once. The organic phase is separated and dried over anhydrous sodium sulfate. The organic phase is then distilled and concentrated to obtain a concentrated organic phase. Finally, the concentrated organic phase is mixed with 2L of anhydrous ethanol to precipitate and crystallize the polycaprolactone material. Finally, the precipitated and crystallized polymer is dried at 50°C to remove the residual solvent.
[0102] Test Example 1
[0103] The polycaprolactone sample containing styrene structure prepared in Example 1 and the polycaprolactone sample without styrene structure prepared in Comparative Example 1 were tested by UV-visible spectrophotometer. The results are as follows: Figure 4 shown.
[0104] The test method is as follows:
[0105] 100 mg of the polycaprolactone sample containing a styrene structure prepared in Example 1 and the polycaprolactone sample not containing a styrene structure prepared in Comparative Example 1 were respectively weighed and dissolved in 10 mL of dichloromethane, and tested under a UV-visible spectrophotometer.
[0106] Depend on Figure 4It can be seen that the polycaprolactone sample containing no stilbene structure prepared in Comparative Example 1 has no ultraviolet absorption under the UV-visible spectrophotometer, while the polycaprolactone sample containing stilbene structure prepared in Example 1 has a strong and obvious absorption peak under ultraviolet light with a wavelength of 100-400 nm.
[0107] The foregoing description is merely a specific embodiment of the present application and is not intended to limit the present application. Persons skilled in the art will readily appreciate that various modifications and variations are possible. Any modifications, equivalent substitutions, or improvements made within the spirit and principles of the present application shall be included within the scope of protection of the present application.
Claims
1. A polycaprolactone material containing a stilbene structure, characterized in that: include: The structural formula of the polycaprolactone material containing stilbene structure is as follows: The ranges of m and n are 20 to 50 respectively.
2. A method for preparing the polycaprolactone material containing a stilbene structure according to claim 1, characterized in that: The preparation method of the polycaprolactone material containing a stilbene structure comprises: reacting a third raw material at a temperature of 105° C. to 120° C. for 20 to 36 hours under the protection of an inert gas, and stopping the reaction when the weight average molecular weight of the product reaches 20,000 to 50,000 as detected by GPC; The third raw material includes 0.02 equivalent to 0.05 equivalent of compound A, 1 equivalent of ε-caprolactone, 0.0001 equivalent to 0.001 equivalent of catalyst and 3 equivalent to 5 equivalents of the second solvent; The structural formula of the compound A is as follows:
3. The method for preparing a polycaprolactone material containing a stilbene structure according to claim 2, characterized in that: Before reacting the third raw material, the second raw material is first heated to reflux the second solvent, and the water in the second raw material is removed by a water separator, and the reflux is maintained for 3h to 5h; The second raw material includes 0.02 equivalent to 0.05 equivalent of compound A, 1 equivalent of ε-caprolactone and 3 equivalents to 5 equivalents of a second solvent.
4. The method for preparing a polycaprolactone material containing a stilbene structure according to claim 3, characterized in that: After the reflux is completed, the water content in the second raw material is sampled and tested to be ≤100 ppm, and then 0.0001 equivalent to 0.001 equivalent of catalyst is added to the second raw material.
5. The method for preparing the polycaprolactone material containing a stilbene structure according to claim 2, characterized in that: After the third raw material completes the reaction, a second mixture is obtained. After the second mixture is cooled to 5°C to 35°C, the second mixture is first diluted with an organic solvent, and then extracted and separated to obtain an organic phase. The organic phase is then distilled and concentrated to obtain a concentrated organic phase. Finally, the concentrated organic phase is mixed with a poor solvent to allow the polycaprolactone material containing a distyrene structure to precipitate and crystallize.
6. The method for preparing the polycaprolactone material containing a stilbene structure according to claim 2, characterized in that: The compound A is prepared by the following method: Under the protection of inert gas, a solution containing titanium tetrachloride is added dropwise to the first raw material in a stirring state. After the addition is completed, the stirring state is maintained at 20° C. to 50° C. for a reaction of 1 h to 12 h; The first raw material comprises 1 equivalent of vanillin, 1.2 equivalents to 3 equivalents of a reducing agent and 20 equivalents to 30 equivalents of a first solvent, and the solution containing titanium tetrachloride comprises 2 equivalents to 4 equivalents of titanium tetrachloride and 10 equivalents to 20 equivalents of a first solvent.
7. The method for preparing a polycaprolactone material containing a stilbene structure according to claim 6, characterized in that: When the solution containing titanium tetrachloride is added dropwise to the first raw material, the temperature of the first raw material is maintained at -70°C to -20°C.
8. The method for preparing a polycaprolactone material containing a stilbene structure according to claim 6, characterized in that: After the first raw material completes the reaction, a first mixture is obtained, and the pH value of the first mixture is adjusted to 1-3 with an acid. After stirring, the mixture is filtered to obtain the compound A solid.
9. The method for preparing a polycaprolactone material containing a stilbene structure according to claim 6, characterized in that: The reducing agent includes any one or more of zinc powder, iron powder and magnesium powder.
10. Use of the polycaprolactone material containing a distyrene structure according to claim 1 in the preparation of surgical sutures, tissue engineering scaffolds and drug sustained-release capsules.
